Literature DB >> 9740432

Oocyte donation in Israel: a study of 1001 initiated treatment cycles.

Y Yaron1, Y Ochshorn, A Amit, A Kogosowski, I Yovel, J B Lessing.   

Abstract

There are numerous studies concerning pregnancy rates in oocyte donation, yet only a handful report the obstetric outcome in such pregnancies. The purpose of this study was to assess factors that influence pregnancy rates, to determine the incidence of complications, and to evaluate obstetric outcome in pregnancies resulting from oocyte donation. This study included 423 oocyte recipients who underwent 1001 oocyte donation cycles at the Oocyte Donation Programme, In-Vitro Fertilization (IVF)-Embryo Transfer Unit, Herzlia Medical Center, Israel. Donors were all healthy women < 34 years old who underwent IVF themselves. In 873 cycles, fertilization occurred and embryo transfer was performed, resulting in 194 clinical pregnancies. Pregnancy rates (PR) significantly declined with the increase in number of previous attempts, and with increasing age of recipient (36.8%/embryo transfer in patients < or = 30 compared to 17.8% in patients > 40 years old). A significant increment in PR was noted with the increasing number of embryos transferred. The overall PR was 22.2%/embryo transfer. However, in young amenorrhoeic patients with normal karyotypes undergoing their first cycle, PR was 52.2%; the 'take home baby' rate was 38.3% per patient undergoing embryo transfer and 17.8% per embryo transfer cycle. A significant increase in the incidence of pregnancy-induced hypertension and a higher proportion of abortions were noted in older patients. A significantly higher incidence of prematurity and low birthweight was observed in multiple pregnancies.

Entities:  

Mesh:

Year:  1998        PMID: 9740432     DOI: 10.1093/humrep/13.7.1819

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  5 in total

1.  Oocyte donation: a risk factor for pregnancy-induced hypertension: a meta-analysis and case series.

Authors:  Ulrich Pecks; Nicolai Maass; Joseph Neulen
Journal:  Dtsch Arztebl Int       Date:  2011-01-21       Impact factor: 5.594

Review 2.  A new era in reproductive medicine: consequences of third-party oocyte donation for maternal and fetal health.

Authors:  Shigeru Saito; Yasushi Nakabayashi; Akitoshi Nakashima; Tomoko Shima; Osamu Yoshino
Journal:  Semin Immunopathol       Date:  2016-06-20       Impact factor: 9.623

Review 3.  Risk of adverse pregnancy and perinatal outcomes after high technology infertility treatment: a comprehensive systematic review.

Authors:  Stefano Palomba; Roy Homburg; Susanna Santagni; Giovanni Battista La Sala; Raoul Orvieto
Journal:  Reprod Biol Endocrinol       Date:  2016-11-04       Impact factor: 5.211

4.  Single-cell transcriptome and cell-specific network analysis reveal the reparative effect of neurotrophin-4 in preantral follicles grown in vitro.

Authors:  Yingchun Guo; Peigen Chen; Tingting Li; Lei Jia; Yi Zhou; Jiana Huang; Xiaoyan Liang; Chuanchuan Zhou; Cong Fang
Journal:  Reprod Biol Endocrinol       Date:  2021-09-04       Impact factor: 5.211

5.  A study of recipient related predictors of success in oocyte donation program.

Authors:  Pooja Gupta; Manish Banker; Pravin Patel; Bhart Joshi
Journal:  J Hum Reprod Sci       Date:  2012-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.